Cite
Predicting of Hepatic Steatosis in Living Liver Donor via CT Liver Attenuation Index (LAI) and Fibroscan Controlled Attenuation Parameter (CAP) Correlation with Biopsy Result.
MLA
Ali Mahfouz, Somaia Mohammed, et al. “Predicting of Hepatic Steatosis in Living Liver Donor via CT Liver Attenuation Index (LAI) and Fibroscan Controlled Attenuation Parameter (CAP) Correlation with Biopsy Result.” QJM: An International Journal of Medicine, vol. 117, June 2024, pp. i254–55. EBSCOhost, https://doi.org/10.1093/qjmed/hcae070.595.
APA
Ali Mahfouz, S. M., eldin Mohamed, F. S., Moneium Chalabi, N. A., & Abdel Rahman, H. I. (2024). Predicting of Hepatic Steatosis in Living Liver Donor via CT Liver Attenuation Index (LAI) and Fibroscan Controlled Attenuation Parameter (CAP) Correlation with Biopsy Result. QJM: An International Journal of Medicine, 117, i254–i255. https://doi.org/10.1093/qjmed/hcae070.595
Chicago
Ali Mahfouz, Somaia Mohammed, Fatma Salah eldin Mohamed, Nivine Abdel Moneium Chalabi, and Hazem Ibrahim Abdel Rahman. 2024. “Predicting of Hepatic Steatosis in Living Liver Donor via CT Liver Attenuation Index (LAI) and Fibroscan Controlled Attenuation Parameter (CAP) Correlation with Biopsy Result.” QJM: An International Journal of Medicine 117 (June): i254–55. doi:10.1093/qjmed/hcae070.595.